Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behaviorFORCONI, Francesco; SOZZI, Elisa; GALLAMINI, Andrea et al.Blood. 2009, Vol 114, Num 21, pp 4696-4702, issn 0006-4971, 7 p.Article